Haemolytic Anaemia Flashcards

1
Q

Normal red cell life cycle

A

Early erythroid –> late erythroid –> polychromatic cells –> mature red cells
Nuclear and cytoplasmic pathways
Senescence (extravascular haemolysis at the spleen into iron, globin and protoporphyrin/bilirubin) – fine balance between production and destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Haemolytic anaemia general features

A

Increased break down of RBC > compensatory production

General features of HA

  • increased red cell breakdown and shortened RBC life span
  • -> anaemia, hyperbilirubinaemia, pigment gallstones, increased LDH, splenomegaly, aplastic crises with parvovirus B19 infection
  • increased red cell production
  • -> reticulocytosis, polychromasia, BM erythroid hyperplasia, folate deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classifications of HA: Extravasular vs Intravascular

A

Extravascular
- breakdown in RE system, resembling normal RBC clearance but at an increased rate

Intravascular

  • breakdown in circulation with direct release of Hb
  • haemoglobinaemia, haemoglobinuria
  • haemosiderinuria (Fe release from Hb)
  • reduced haptoglobin (proteins that bind free Hb in plasma to “clean up”)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classifications of HA: Intrinsic red cell defect vs Extracorpuscular factors

A

Intrinsic red cell defect (usually inherited)

  • membrane: hereditary spherocytosis, elliptocytosis
  • enzyme: G6PD or pyruvate kinase deficiency
  • Hb: Hb variants

Extracorpuscular factors (acquired)

  • immune: auto/alloimmune
  • non-immune: red cell fragmentation syndromes, infection, chemicals/drugs/physical agents, secondary to systemic diseases
  • PNH (acquired intrinsic red cell defect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Intrinsic red cell defect: membrane - hereditary spherocytosis (inheritance pattern, pathogenesis, clinical features, diagnosis, treatment)

A

Proteins in the membrane essential for maintaining integrity of the RBC and allow them to deform and squeeze through microcirculation

Hereditary Spherocytosis

  • AD, variable expression, can be due to germline de novo mutation
  • defects in proteins involved in the vertical interactions between membrane skeleton and lipid bilayer –> lose biconcave shape and increased fragility
  • clinical features: splenomegaly and gallstones common, increased MCHC, spherocytes (loss of central pallor) +/- polychromasia

Diagnosis:

  • osmotic fragility test (historically)
  • FLOW CYTOMETRY for eosin-maleimide (EMA) binding to red cells –> lower fluorescence due to less membrane protein expression and reduced SA:Vol in spherocytes
  • negative direct coombe’s test (r/o AIHA)

Treatment:

  • folate replacement
  • monitor growth and development
  • splenectomy/cholecystectomy depending on symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intrinsic red cell defect: membrane - other defects

A

Hereditary elliptocytosis

  • elliptocytes on blood film
  • milder than HS

SE asian ovalocytosis

  • Band 3 protein defect
  • ovalocytes and stomatocytes (advantage in malaria resistance)
  • mostly asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Intrinsic red cell defect: enzyme - G6PD deficiency (pathophysiology, inheritance, clinical features, precipitating factors, diagnosis, treatment, prevention)

A

Normal function: reduction of NADP to NADPH for production of reduced glutathione for anti-oxidation
- deficient G6PD increases RBC susceptibility to oxidant stress e.g. fava beans, mothballs (napthalene), drugs (antimalarials, septrin, nitrofurantoin, HD aspirin)

X linked recessive, affecting males
Female carriers have advantage of malaria resistance

Clinical features:

  • usually asymptomatic unless exposed to oxidant stress –> acute intravascular HA
  • neonatal jaundice

Diagnosis:

  • blood smear: polychromasia, reticulocytosis, “bite” cells, HEINZ BODIES (denatured Hb; ring-like)
  • G6PD assay (falsely normal during acute haemolysis as G6PD levels higher in reticulocytes)

Treatment:

  • stop offending drugs and treat infections
  • maintain urine output to prevent renal toxicity of free Hb

Routine antenatal screening in HK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Intrinsic red cell defect: Hb

A

Refer to other set of flashcards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Extracorpuscular factors: immune - types

A

Autoimmune (AIHA)

  • Ab against own RBC
  • POSITIVE DIRECT COOMBE’S TEST
  • cold and warm types

Alloimmune HA

  • mainly concerning transfusion and transplantation (Ab of one individual reacts with another’s RBC)
  • also related to haemolytic disease of newborn (RhD alloimmunisation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Direct and Indirect Coombe’s test

A

Direct

  • test for RBC coated with Ab
  • add anti-human globulin (anti-IgG and anti-C3d) to patient’s blood and check for agglutination

Indirect

  • for pretransfusion testing for Ab in plasma
  • add test RBCs and anti-human globulin and check for agglutination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Warm AIHA - pathogenesis, clinical features, causes, treatment and support

A

Pathogenesis: autoimmune IgG Ab
- IgG coated RBC taken up by macrophages in RE system (spleen) and part of coated membrane lost –> red cells come progressive spherical

Clinical features:

  • splenomegaly
  • features of extravascular HA
  • spherocytosis (c.f. distinguish from HS by DCT)
  • DCT positive (anti-IgG)
  • Evan’s syndrome when a/w ITP

Causes:
- idiopathic, SLE, lymphoma, CLL, drugs (e.g. methyldopa)

Treatment:

  • remove underlying cause e.g. stop drugs, treat AI disease, treat lymphoma (mostly idiopathic)
  • steroid
  • if steroid ineffective: splenectomy, monoclonal Ab (rituximab anti-CD20), other immunosuppressants

Supportive treatment:

  • folic acid
  • blood transfusion if severe symptomatic anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cold AIHA - pathogenesis, clinical features, lab findings, causes, treatment

A

Pathogenesis: autoimmune IgM Ab (anti-C3d) which is highly efficient at fixing complement
- mostly against I antigen on RBC

Clinical features:

  • chronic HA aggravated by cold
  • intravascular haemolysis
  • acrocyanosis of fingers, toes, nose, ears

Lab findings

  • less marked spherocytosis
  • red cell agglutination in cold
  • DCT positive (anti-C3d)

Causes:

  • idiopathic, lymphoma, infections (Mycoplasma pneumonia, infectious mononucleosis)
  • paroxysmal cold haemoglobinuria

Treatment:

  • keep warm
  • treat underlying cause
  • Rituximab
  • splenectomy/steroids not useful
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Paroxysmal cold haemoglobinuria

A

Rare
Intravascular haemolysis after exposure to cold then warm temp due to anti-P IgG Ab

Donath-Landsteiner test

A/w malignancies, viral infections, syphilis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Extracorpuscular factors: non-immune - causes, main features

A

Red cell fragmentation syndromes
- caused by altered blood flow follow cardiac surgery or AVM or pathological small blood vessels i.e.g Microangiopathic HA – SCHISTOCYTES + HA

  • ABNORMAL THROMBOSIS at inappropriate sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Red cell fragmentation: TTP - pathogenesis, clinical features, coagulation time, diagnosis, associations

A

Thrombotic thrombocytopenic purpura

Pathogenesis: ADAMTS13 deficiency = increase HMW vWF which are more thrombogenic –> clot formation at random sites
Rapidly fatal emergency!

Clinical features:

  • classical pentad (fever, MHA, thrombocytopenia, renal impairment, fluctuating neurological signs)
  • normal coagulation time
  • haemolysis features
  • markedly reduced ADAMTS13 activity

Difficult diagnosis:

  • ADAMTS13 activity not widely available for testing
  • often full pentad not present
  • must be on DDx when there is MHA and thrombocytopenia!! (other DDx are DIC and HUS)

Associated with drugs, malignancies, infections, pregnancy, autoimmune diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Red cell fragmentation: HUS - pathogenesis, clinical features, typical vs atypical

A

Haemolytic uraemic syndrome

Pathogenesis: not due to ADAMTS13 deficiency

==> MHA and thrombocytopenia

Clinical features: minimal neurological impairment but severe renal impairment

Typical HUS: gastroenteritis with E.coli and shigella
Atypical HUS: no preceding gastroenteritis but can be triggered by infections

17
Q

Red cell fragmentation: DIC - pathogenesis, clinical features, lab results, causes, treatment

A

Disseminated intravascular coagulation
- Another DDx of MHA and thrombocytopenia

Pathogenesis: Activation of systemic coagulation (pathological thrombin) with intravascular deposition of fibrin –> widespread thrombosis

Consumption coagulopathy with decreased coagulation factors and platelets

Clinical features:

  • increase bleeding and thrombosis
  • prolonged PT/ APTT, reduced fibrinogen, increased D-dimer (fibrin degradation product)

Caused by infections (e.g. GN/meningococcal septicaemia), malignancy (e.g. APL, mucin-secreting adenoCA), obstetric complications (pre-eclampsia), widespread tissue damage e.g. trauma, burns, HSR

Treatment: supportive and treat underlying cause
- don’t give platelets pre-emptively or unnecessarily!

18
Q

Intrinsic acquired RBC defect: Paroxysmal Nocturnal Haemoglobinuria - pathogenesis, clinical features, associations, diagnosis, treatment

A

Clonal disorder of marrow stem cell

  • -> Somatic mutation in PIG-A which is a GPI anchor for CD55 and CD59 proteins
  • CD55 (decay activating factor), CD59 (membrane inhibitor of reactive lysis)

==> Render RBC sensitive to complement mediated lysis –> chronic intravascular haemolysis

Clinical features: haemosiderinuria (dark urine; iron def possible), thrombosis
Association with aplastic anaemia + myelodysplasia; sometimes pancytopenia

Diagnosis: flow cytometry for loss of GPI anchors/proteins (PNH type I cells = normal; type III = no GPI linked proteins)

Treatment: anticoagulation, immunosuppression, HSCT, Ecluzimab (antibody against C5)